Autonomous Research has revised its price target for T. Rowe Price Group (TROW) to $83, down from $87, while maintaining an “Underperform” rating on the stock. This adjustment reflects a moderated outlook on the investment management company’s future performance. The article also touches upon a recent increase in T. Rowe Price’s stake in Brazil’s Vivara.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Autonomous Research Adjusts T. Rowe Price Group PT to $83 From $87, Maintains Underperform Rating
Autonomous Research has revised its price target for T. Rowe Price Group (TROW) to $83, down from $87, while maintaining an “Underperform” rating on the stock. This adjustment reflects a moderated outlook on the investment management company’s future performance. The article also touches upon a recent increase in T. Rowe Price’s stake in Brazil’s Vivara.